BridgeMD
New treatment option for Renal Carcinoma
Official title Comparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney (COMPAR-K)
ClinicalTrials.gov ID: NCT06290427
What this study is testing
- What it's testing
- The Urology Unit of AOUI Verona proposes a clinical study aimed at a preliminary evaluation of postoperative complications specifically focused on robotic partial nephrectomy (RAPN) procedures using two currently available platforms: DaVinci®; Hugo®. The questions it aims to answer are: Does the estimation of the post-operative complications suggest something?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90
You may be able to join if
- patient aged between 18 and 90 years old;
- patient with localized kidney tumor suitable for partial nephrectomy;
- patient able to understand and sign the informed consent;
- patient compliance with the follow-up program.
You likely can't join if
- patient who do not fall within the inclusion age range;
- patient not suitable for partial nephrectomy;
- patient unable to understand and sign the informed consent;
- patient unable to follow the monitoring program;
- patient refusal to participate to the study.
The study team makes the final eligibility decision.
Where it's taking place
- Verona, VR, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Verona, VR, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.